Moderna (MRNA) 2025 revenue outlook of about USD 1.9bln (exp. USD 1.89bln) and improving 2025 expected GAAP operating expenses by USD 200mln to USD 5-5.2bln

Newsquawk Staff · 12 Jan 2026, 12:20 UTC

Cash, cash equivalents and investments at year-end 2025 about USD 8.1bln.
Expects GAAP operating expenses of USD 4.2-4.6bln in 2027, targeting cash breakeven in 2028.
Reiterates plan to deliver up to 10% revenue growth and GAAP operating expense reductions in 2026.
Potential first approvals of flu and flu/covid combination products in 2026.

What it means

Moderna's 2025 revenue outlook slightly beats expectations, indicating a modestly optimistic growth trajectory. The decrease in expected operating expenses suggests improved cost management, which, paired with their growth forecast and potential product approvals, could enhance investor sentiment. This performance insight is crucial for evaluating Moderna's positioning in the biotech sector and its impact on stock valuation.

What our latest note said

US Market Open, 6 Nov, 10:48 UTC · what it led with

APAC stocks were pressured; KOSPI slumped 6% following hefty losses in Samsung and SK Hynix.
USD is firmer against all G10 peers awaiting the US NFP report.

Read the whole note Free to read.

Newsquawk Daily

Get the next one free, by email.

What moved overnight, where stocks, bonds, currencies and oil stand, and what’s due today. Written by our analysts.

Both market-open notes, EU and US, every weekday. No account needed. Unsubscribe any time.

If you trade

This headline was on the Newsquawk live feed at 12:00 UTC.

Use the Platform opens our news terminal in your browser, with the live headline feed. It’s news, not a broker.

Use the Platform

Free. No signup, no card.

Case studies

Headlines that moved markets

FX headlines from our feed, and what the market did next.

Iranian President Pezeshkian says the Supreme Leader has granted the government some authority on dialogue, ISNA reports.
EUR/USD+0.1%
ECB policymakers see a December rate hike followed by a pause; New ECB staff estimates show the rise in bond yields cutting growth by a cumulative 100bps and inflation by 90bps in 2027-28 vs the September baseline, according to reports, citing sources.
EUR/USD−0.1%
ECB President Lagarde (Q&A) says policymakers believe they are in a good position to wait for incoming information. The situation they are in could have warranted a hike.
EUR/USD+0.1%

See all 221

More on this story

Make Newsquawk a preferred source on GoogleSelect this to see Newsquawk more often in Top Stories when you search Google.

What it means

More on this story

Related headlines